RA Capital Management Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 31
- Investments
- 190
- Portfolio
- 70
- Exits
- 108
RA Capital Management General Information
Description
Founded in 2001, RA Capital Management is a venture capital firm and is based in Boston, Massachusetts. The firm focuses on evidence-based investing in public and private healthcare and life science companies developing drugs, medical devices, and diagnostics. The firm also manages hedge funds.
Contact Information
Website
Year Founded
2001
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Hedge Fund
Primary Office
- 200 Berkeley Street
- 18th Floor
- Boston, MA 02116
- United States
+1 (617) 000-0000
RA Capital Management Investments & Acquisitions (190)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| T-Knife | 06-Aug-2020 | Early Stage VC | 000.00 | Drug Discovery | Clinical Trials - Phase 1 | 000000 0000000 00 |
| 00000000 | 05-Aug-2020 | 0000 00000 | 0000 | Drug Discovery | Startup | |
| 000 000000 | 03-Aug-2020 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | |
| 0000000 0000000000 | 30-Jul-2020 | 0000 | 00000 | Drug Discovery | Generating Revenue | |
| 000000 000000 | 17-Jul-2020 | 0000 | 00000 | Drug Discovery | Generating Revenue | |
| 000000 | 13-Jul-2020 | 0000 | 000.00 | Drug Discovery | Generating Revenue/Not Profitable | |
| 000 000000000 | 07-Jul-2020 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue | 000000 0000000 00 |
| 000000 00000000000 | 02-Jul-2020 | 00000 00000 | 000.00 | Biotechnology | Clinical Trials - Phase 1 | 000000 00000 00.0 |
| Bolt Biotherapeutics | 01-Jul-2020 | Later Stage VC | 000.00 | Drug Discovery | Generating Revenue | |
| Artiva Biotherapeutics | 26-Jun-2020 | Early Stage VC | 0000 | Drug Discovery | Startup | 00000 0000000 00.0 |
RA Capital Management Exits (107)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Inozyme Pharma | 24-Jul-2020 | IPO | 00000 |
| 00000 000000000000 | 24-Jul-2020 | 000 | 00000 |
| 0000000 0000000000 | 17-Jul-2020 | 000 | 00000 |
| 000000 00000000000 | 13-Jul-2020 | 000 | 00000 |
| 00000 | 08-Jul-2020 | 000000 0000000000 | 000.00 |
| 000000 | 26-Jun-2020 | 000 | 00000 |
| 00000 000000000000 | 19-Jun-2020 | 000 | 00000 |
| 0000000 | 12-Jun-2020 | 000 | 00000 |
| Legend Biotech | 05-Jun-2020 | IPO | 00000 |
| Lyra Therapeutics | 01-May-2020 | IPO | 0000 |
RA Capital Management Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialRA Capital Management Team (57)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Kai Wu | Chief Financial Officer | Boston, MA | |||
| Amanda Daniels | Chief Operating Officer | Boston, MA | |||
| Andrew Levin Ph.D | Managing Director | 00 | 0 | 0 | Boston, MA |
| Peter Kolchinsky Ph.D | Founder & Managing Partner | 00 | 0 | 0 | Boston, MA |
| Rajeev Shah | Managing Partner | 00 | 0 | 0 | Boston, MA |
RA Capital Management Co-Investors (269)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Cormorant Asset Management | 13 | 0 | 0 |
|
|
| OrbiMed | 00 | 0 | 00 |
|
|
| Perceptive Advisors | 00 | 0 | 0 |
|
|
| Janus Henderson Investors | 00 | 0 | 0 |
|
|
| Foresite Capital Management | 0 | 0 | 0 |
|
|